Phreesia

PHR

Market cap $560M

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Investors in Phreesia, Inc. (NYSE: PHR) lost between 29% of their holdings on March 30, 2026, after the Company cut FY 2027 revenue guidance to $510-$520 million -- down from the $545-$559 million range issued just months earlier. Shareholders who lost money on PHR are encouraged to submit their information now to discuss their legal rights.

Phreesia guided FY 2027 revenue at $545-$559 million while internal visibility into key segments was already deteriorating -- shareholders who lost money when the guidance was slashed to $510-$520 million may have legal rights. NEW YORK, April 15, 2026 /PRNewswire/ -- Phreesia (NYSE: PHR) shareholders lost between 29% of their investment in a single session on March 30, 2026, after the Company cut FY 2027 revenue guidance by as much as $49 million -- from a prior range of $545-$559 million down to $510-$520 million.

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named to Becker's Hospital Review's 2026 list of “Revenue Cycle Management Companies to Know.” The annual list recognizes companies that play a critical role in helping healthcare organizations manage the growing complexity of revenue cycle operations, including patient access, intake, billing and reimbursement. The 2026 list highlights organizations driving innovation a.

New York, New York--(Newsfile Corp. - April 13, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE: PHR) concerning potential violations of the federal securities laws. On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year 2027, we expect revenue to be in the range of $545 million to $559 million.

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--MediFind received the DiMe Seal, developed by the Digital Medicine Society, an independent nonprofit advancing the safe use of digital health.

New York, New York--(Newsfile Corp. - April 8, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE:PHR) concerning potential violations of the federal securities laws. On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year 2027, we expect revenue to be in the range of $545 million to $559 million.

LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Phreesia: Market Delivers A Resounding Vote Of No Confidence (Rating Downgrade)